Peer Review History
| Original SubmissionJanuary 29, 2025 |
|---|
|
PONE-D-25-04838-->-->Do you really want to see a 2-year-old suffer? Understanding people’s views on the relative value of health gains by age-->-->PLOS ONE?> Dear Dr. De Silva, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 09 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Paolo Landa, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. 3. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 4. One of the noted authors is a group or consortium QUOKKA. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address. 5. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 6. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement. 7. One of the noted authors is a group or consortium QUOKKA. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address. 8. Please remove all personal information, ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Note: spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. Additional Editor Comments : Please address the reviewers comments provided [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: The study explores an important topic, providing insight into how people value health gains by age. However, several methodological and clarity issues need to be addressed: • The title, "Do you really want to see a 2-year-old suffer?", may be misleading. The study examines preferences for health gains across a broader age range (1 month to 24 years) rather than focusing solely on very young children. • The study relies on interviews conducted while participants completed questionnaires, which may introduce bias. Participants might feel pressured to prioritize children or refrain from explicitly stating they do not prioritize based on age. Clarification is needed on how potential biases were addressed. • Recruitment method is not described in detail. If participants were not randomly selected, selection bias could impact the generalizability of findings (Lines 221-222). • Definition of “parents of children with a health condition” (Line 132): The restriction to children aged 19 and above is unclear. Why exclude parents of younger children with health conditions? • Recruitment details (Lines 145-147): The description does not mention parents of healthy children, yet they were included in the study. Clarification is needed. • Representativeness of the sample (Lines 148-150): The sample draws from the P-MIC study, which included parents of children aged 2-18 at a single hospital. This limits generalizability of the population. Grammar and Clarity Issues • Line 248: "participants considered self-awareness of death When choosing between..." • Line 273: "Nine participants identified differences in a person’s their ability to work." • Lines 501-502: "explained by our participants as being due the broad categories used in the attitudinal questions." • Line 540: TTO typo Reviewer #2: This is a well-conducted research article, but I have the following questions and suggestions for improvement: 1.Rationale for Sample Size: The quantitative section (PTO questionnaire) should include a more detailed justification for the sample size calculation, such as power analysis parameters (e.g., α value, effect size, and target power). Clarify the data saturation criteria for qualitative interviews, particularly for small sample subgroups (e.g., adolescents, n = 7; parents of sick children). Specify whether saturation was determined by theme repetition rate or the occurrence of negative cases. 2.Justification for Age Selection: Explain in the methodology or discussion why the study focuses on 2-year-olds rather than other age groups (e.g., 3 or 4 years old). If the selection is based on policy guidelines (e.g., Australian Pediatric Guidelines' age thresholds), please cite the relevant sources. 3.Results Optimization: Chart Clarity: Figures 1 and 2 (schematic diagram of case issues and thematic framework) appear vague, making the text difficult to read. Consider improving clarity and resolution for better comprehension. 4.Negative Case Reporting: The results primarily support the "children first" argument. To ensure a balanced discussion, include citations of perspectives opposing this principle (e.g., views prioritizing adult productivity). This will help mitigate potential selection bias. 5.Discussion on Cultural Generalizability: Consider discussing whether findings from the Australian sample apply to collectivist cultures, such as East Asian societies, which may prioritize elder care. This should be acknowledged as a potential limitation. 6.Ethics and Data Transparency: While the study states that "verbatim transcripts of interviews are ethically restricted from publication," consider making anonymized subject codebooks publicly available to enhance methodological transparency and reproducibility. Reviewer #3: Thank you for the opportunity to review this manuscript, which qualitatively examines societal perspectives on age-related prioritization in healthcare resource allocation. The authors have approached the research question thoroughly and I enjoyed reading this manuscript. Abstract: The abstract is clear and well-structured. However, it would enhance clarity if the authors explicitly mentioned how these qualitative insights could inform resource allocation decisions. Introduction: The introduction effectively situates the study but could benefit from deeper theoretical grounding. Specifically, it would be valuable to explicitly reference ethical theories (e.g., "fair innings" theory, capability approach, or distributive justice theories) to contextualize age-based prioritization debates. Methods: - Recruitment (Lines 146-147): It is noted that two recruitment methods were used (CRNRSTONE and QUOKKA’s P-MIC sample). Please explicitly discuss potential differences in socioeconomic or demographic characteristics between these recruitment strategies and their implications for the study. Consider adding a detailed table comparing demographic characteristics between groups. Survey Design Line 156 references a protocol, which is referenced elsewhere in the paper as established evidence that adolescents coped well with interviews. This does not seem correct, can you clarify? What were the age groups of the pilot interviews? Lines 170-171. Figures 1 and 2 in the appendix are not legible. Data collection: The authors describe that there were two pilots and iterations were made. What were the changes made? The authors do not describe any reflexive approaches, they also do not describe the potential biases they may bring into this research as a result of their positionality. This is later described in the limitations section, but more information is still needed on positionality and reflexive approaches taken to mitigate potential bias. Data analysis: The data analysis section (lines 208-) are sparse and do not describe how themes were chosen. “The final stages included analyzing the data according to demographic characteristics of the participants and linking the qualitative results to the quantitative findings” what demographic characteristics? There are no details on how data were coded into themes under the analysis section, by whom, and whether disagreements or reliability in coding were considered. Provide your resulting coding framework as per your method. Results Eleven themes are alot for qualitative research. Some of these themes seem very minor. For example, Theme 10 appears to only be supported by a few participants. This is not a major recurrent theme and should be moved to a minor section. Throughout, it is sometimes unclear whether themes are well supported by the data, or if this is a minor divergent theme. The distinction between major and minor, and divergent cases should be made. When divergent cases are included, ensure that they directly relate to your research question. This is also related to aim 5 - Saturation (Lines 219-222): Clarify precisely when thematic saturation was reached. Current wording implies saturation occurred around the 39th-41st interview. A concise statement indicating exactly at which interview thematic saturation occurred would enhance methodological rigor. Further (related to above point) because there were 11 themes which is more than the average qualitative paper, when was saturation for each reached? Did some themes reach saturation more quickly than others? - PTO methods: Some participants expressed discomfort or uncertainty when responding to PTO questions. The manuscript should critically address whether PTO remains suitable given participants' discomfort and the emotional bias introduced. Could the authors discuss alternative methods (e.g., Discrete Choice Experiments or Relative Social Willingness-to-Pay) and justify their continued use of PTO despite these limitations? Results: - Adolescent vs parent opinions: The manuscript clearly highlights differences between adolescents’ and parents’ prioritizations. It would strengthen the analysis to explicitly link these differences to the theoretical or empirical literature on intergenerational equity. - Interpretation of PTO questions: Themes identified are insightful but primarily descriptive. The analysis would benefit from deeper interpretation. For example, how do these themes inform our broader understanding of resource allocation, especially concerning fairness, equity, and efficiency? - Minor Errors: Line 540 incorrectly refers to TTO instead of PTO, which is confusing and should be corrected. Discussion: While QALYs do not typically incorporate explicit age weights, discussing the ethical debates around age weighting in DALYs (as done historically) would be relevant here. Explicitly mention pros (e.g., potential societal consensus on fairness) and cons (e.g., equity concerns, comparability) associated with explicit age weighting as per Murray et al. (2012) and Vos et al. (2012). Provide greater integration of qualitative findings with the quantitative results from your companion quantitative PTO study. Specifically, explain clearly how qualitative data enrich or challenge the quantitative conclusions. - Limitations: Explicitly discuss how the single-gender (female) of interviewers might have influenced participant responses, particularly given the sensitive nature of the topic. Conclusion The conclusion does not cover the 5 aims discussed in the introduction. Include a brief overview of the ways in which the five aims are concluded. There are bits a pieces throughout the manuscript, but there is sometimes an unclear link between the aim and the results/discussion. When I read the conclusion, I am not sure that I walk away with a clear understanding of the aims. Minor issues: - Reference [29] is an unpublished manuscript currently unavailable online. Clarify its accessibility or update with available published references if possible. - Consistently clarify the terminology regarding age categories to avoid confusion between “children,” “adolescents,” and “young people.” ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. De Silva, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: The reviewers found many elements to modify in order to improve your manuscript. Please submit your revised manuscript by Oct 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Paolo Landa, Ph.D. Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #4: (No Response) Reviewer #5: All comments have been addressed Reviewer #6: All comments have been addressed Reviewer #7: All comments have been addressed Reviewer #8: (No Response) Reviewer #9: All comments have been addressed Reviewer #10: (No Response) Reviewer #11: All comments have been addressed Reviewer #12: (No Response) Reviewer #13: All comments have been addressed Reviewer #14: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes Reviewer #7: Yes Reviewer #8: Yes Reviewer #9: Yes Reviewer #10: Partly Reviewer #11: Yes Reviewer #12: Yes Reviewer #13: Yes Reviewer #14: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes Reviewer #7: Yes Reviewer #8: Yes Reviewer #9: N/A Reviewer #10: Yes Reviewer #11: Yes Reviewer #12: Yes Reviewer #13: N/A Reviewer #14: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes Reviewer #7: Yes Reviewer #8: Yes Reviewer #9: Yes Reviewer #10: Yes Reviewer #11: Yes Reviewer #12: No Reviewer #13: No Reviewer #14: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes Reviewer #7: Yes Reviewer #8: Yes Reviewer #9: Yes Reviewer #10: Yes Reviewer #11: Yes Reviewer #12: Yes Reviewer #13: Yes Reviewer #14: Yes ********** Reviewer #4: Additional Comments: Dear author, I understand the importance of evaluating the personal rules involved in choices regarding investments in health programs by age. In your article, I missed the addition of scientific studies on health outcomes related to the age of patients which should be also included to help decision-making. See, for example, articles on investments in health in early childhood. I suggest that you add some references to articles in this sense and that you mention the importance of such a source of decision-making in health. Reviewer #5: Authors addressed all comments raised by the reviewer in beautiful manner. Now this manuscript is ready for publication. Reviewer #6: Title: The title precisely reflects the subject of the study; however, it is academically advantageous to consider substituting the term "people" with "public." “A qualitative study to understand public views on the relative value of health gains for children and young people compared to adults” Abstract: • Methods: Concise overview. Nonetheless, I suggest the inclusion of the following statement at the last line of the methods used paragraph: “Thematic analysis was employed to identify fundamental reasoning patterns.” Introduction: The introduction is thorough and based in robust research. However, Structural enhancements are necessary to improve the clarity and scholarly tone, such as: • Lines (108 –128), (129-142), The paragraphs are too dense and long, consider break them into clear paragraphs. • Line 113, those who have not had their fair innings needs to be prioritized. Change needs to “need” • Line 120, consider changing >5 years to “older than 5 years” for more academic tone. Methods: Demonstrate methodological transparency, provide a strong rationale for recruitment, and offer clear justification for the selections. Nevertheless, it requires slight modifications for improved clarity, formatting, and organization. • Recruitment and Participants: Lines (164-179) and (180-192) consist of extensive paragraphs; please divide them into shorter paragraphs. • Survey Design: The paragraph is extensive, consisting of lines 198-210. It is desirable to divide it into two paragraphs. • Data Collection: The paragraphs lines (218-227) and (233-253) are extensive; therefore, it is necessary to divide them into separate paragraphs. Results: • Participants section: It is well written; however, please divide it into paragraphs for enhanced readability. • Qualitative Results: it is well organized and comprehensive, but consider this: a) rewrite the sentence “Another participant chose the 40-year-olds over the 8-year-olds” in the line 333, for more academic tone “participants aged 40 over those aged 8” b) line 337 change the statement “people who are younger have to walk a lot more than someone who's 40” to “Younger participants were viewed as more reliant on physical mobility, compared to those who are 40 years old” c) Theme 5: Provide a short analytical statement elucidating the reason for this and why it happened for instance, “Despite the guidance, participants struggled to disengage from real-world connections to chronic illness, illustrating the psychological challenge of ‘bracketing’ prolonged considerations.” Discussion: This discussion is substantial and effective, but it can be enhanced through refinement in: • lines (535-554) and (637-662), are lengthy, please divide them into paragraphs. • Line 566-571 showing your novel contribution to the literature and the readers need to see this, so please add a statement that clarify this in the line 571 such as “To our knowledge, this is the first study to document………” • Line 542, change the informal statements please “unable to imagine” to “had difficulty conceptualizing” Conclusion: It offers clear alignment with study objectives, acknowledges cognitive and emotional complexity, and is relevant to policy and methodology. However, please consider some amendments such as: • Line 674, These interpretations were reasoned by factors such as… change to These interpretations were influenced by factors such as… (for an elevated research tone). • Replace informal language with academic ones such as line 671 “drawing on emotional reaction” to “triggering emotional response”, and line 676 “what they might experience if they live” to “anticipated life experiences” • Add word “Additionally” before (4) When subjected to alternative viewpoints… (To enhance the coherence between sentences for improved readability). • The conclusion indicates that four out of five aims were addressed; however, it does not provide a brief explanation for the aim that was not addressed. A brief mention would enhance transparency. • The final sentence suggests practical relevance; however, the conclusion would be enhanced by adding a strong closing statement regarding the implications of the findings for healthcare policymakers, PTO methodology, or valuation research. Please consider adding this. Reviewer #7: Thank you for the invitation to review. The authors have appropriately revised their manuscript in accordance with the previous reviewers' requirements. I believe the manuscript now meets the standards for publication in PLOS ONE, and I recommend its acceptance. Reviewer #8: I have some few observations on the study title which to be address by the authors to facilitate reading and better understanding by the authors A qualitative study to understand some selected individual's views on the relative value of health gains for children and young people in..... (here the name of the exact place where the study took place must be mentioned.) in Australia compared to Adults .....(which year was the study conducted )? Methods Under line 181 which says that adolescents and adults without children -Can the authors describe and elaborate further on what they meant by without children whether biological or adopted children or had children but are not staying with them (empty net syndrome ) Pre-testing of questionnaire, were the questionnaire pre-tested and where were they pre-tested (pretesting of questionnaire cant take place in the study area) . In line 631 there is an incomplete statement some strengths of the study were that we included an adolescent sample to address the research gap identified review by...this part of the statement must be concluded with purpose and meaning. Conclusion. Since the study was not conducted in the entire Australia the Authors cant conclude that the study explored the views of Australians but a statement can be made to cover the exact geographical location where the study took place. check line 630 where you talked about addressing four of the five aims set out,can the authors explain why the 5th aim was not address in the study or why it is not mention in the write-up Reviewer #9: I consider this to be an interesting article, and one that warrants further work on the subject. I believe that the authors have taken the reviewers' corrections seriously, which has helped them to improve their manuscript. Reviewer #10: Thank you for submitting this interesting manuscript entitled “Spatial epidemiology of dengue in northeastern Thailand: A Bayesian approach.” The study addresses an important public health issue and employs Bayesian spatial modeling, which is an appropriate and modern approach for investigating dengue distribution. The manuscript is promising, but several revisions are needed before it is suitable for publication. 1. Study design and data sources - The use of surveillance data is appropriate, but please elaborate more on the limitations such as underreporting, case definition, and ecological fallacy. - Clarify whether population denominators and case counts were adjusted for potential reporting inconsistencies across districts. 2. Bayesian modeling and statistical details - The CAR/BYM approach is suitable, but details on prior distributions, convergence diagnostics (e.g., trace plots, R-hat, ESS), and sensitivity analysis should be added. - Explain more clearly how model fit was assessed and whether alternative specifications were tested. 3. Results and interpretation - Relative risk and credible intervals are appropriate outputs, but please avoid causal interpretations. The results should be framed as spatial associations rather than direct effects. - Highlight that the global autocorrelation results were not significant, and focus more on local clusters. 4. Figures and tables - Improve figure legends for clarity, especially when reporting cluster categories (HH, HL, LH, LL). - Tables could be reformatted to improve readability (e.g., Tables 2 and 3). 5. Discussion and limitations - Expand on limitations of Bayesian smoothing, surveillance-based data, and cross-sectional design. - Consider linking the findings more explicitly to public health implications, such as targeting vector control or surveillance. 6. Language and style - The manuscript is written in clear English but would benefit from minor editing to shorten long sentences and improve readability. Overall recommendation: Major Revision. The manuscript has scientific merit and novelty but requires clarification of methods, stronger discussion of limitations, and improved presentation of results. Reviewer #11: This is a strong qualitative study that provides nuanced insights into societal views on age-related healthcare prioritization. With minor clarifications and refinements as suggested, the manuscript will make a valuable contribution to the literature on health economics, ethics, and resource allocation. Reviewer #12: Clarify Terminology Consistently: Ensure consistent use of terms like “children,” “adolescents,” and “young people” throughout the manuscript and figures to avoid confusion. Improve Figure Quality: Figures 1 and 2 (PTO examples) and Figure 3 (Framework Analysis) should be provided in high-resolution, publication-ready format. Ensure all text is legible. Reflexivity and Positionality: While limitations are acknowledged, consider briefly expanding on how the interviewers’ backgrounds as economists may have influenced data interpretation, not just data collection. COREQ Checklist: Ensure the COREQ checklist (S4 Table) is complete and accurately reflects the study’s reporting. Reference Formatting: Some references (e.g., [23]) are still marked as “unpublished manuscript.” If now published, update citation details accordingly. Reviewer #13: Congratulations to the author for conducting qualitative research on a very pertinent topic that will guide the policy makers for decision making. However, there are few suggestions to improve the quality of the research paper. Please mention the type of qualitative research conducted, what were the strategies used to maintain the rigor of the qualitative study, what method/framework was used for the qualitative data analysis? Moreover, author need to describe in methodology, how many researchers were involved in data collection, how was the inter-coder's reliability data transparency checked? Conclusion could be written aligned to objectives in a comprehensive manner. All the best for final revisions and publication of the revised manuscript. Reviewer #14: Concerns from previous reviewers have been addressed adequately, I have just raised minor concerns and add comments that could further improve the document. I support that the manuscript is accepted for publication ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #4: No Reviewer #5: Yes: Dr. Ragni Kumari Reviewer #6: No Reviewer #7: Yes: Xuanjie Chen Reviewer #8: Yes: Dr.Justice Ofori-Amoah Reviewer #9: No Reviewer #10: No Reviewer #11: Yes: Dr Neha Asif Reviewer #12: Yes: Raul Alberto Carrilho Cordeiro Reviewer #13: Yes: Jarina Begum Reviewer #14: Yes: Veuvette Ngalulawa Kone ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
<p>A qualitative study to understand public views on the relative value of health gains for children and young people in Australia compared to adults PONE-D-25-04838R2 Dear Dr. De Silva, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Paolo Landa, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): The authors well answered to the reviewers and improved the manuscript considering the quality standards of the journal. Congratulation to the authors for the great result. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #5: All comments have been addressed Reviewer #7: All comments have been addressed Reviewer #8: All comments have been addressed Reviewer #12: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #5: Yes Reviewer #7: Yes Reviewer #8: Yes Reviewer #12: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #5: (No Response) Reviewer #7: Yes Reviewer #8: Yes Reviewer #12: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #5: Yes Reviewer #7: Yes Reviewer #8: Yes Reviewer #12: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #5: Yes Reviewer #7: Yes Reviewer #8: Yes Reviewer #12: Yes ********** Reviewer #5: Thank you for the opportunity to review this revised manuscript. The authors have satisfactorily addressed previous reviewer comments, including expanding the literature on age-related health outcomes, and clarifying their qualitative methodology and results interpretation. The study is technically sound, uses appropriate methods, and the data support the conclusions well. Ethical standards are upheld, and data availability is adequately described. The manuscript is clearly written in standard English and is presented intelligibly for the journal readers. I recommend acceptance of this manuscript for publication in PLOS ONE. It provides original, valuable insights into public preferences on age-based health prioritization and will contribute meaningfully to healthcare resource allocation literature. Reviewer #7: (No Response) Reviewer #8: Errors and typos identified are rectified by the authors,given the large study area,study participants and the objectives of the study the authors can consider getting more publications Reviewer #12: No further comments. Main comments have been adressed before. The main recomendations from all rewieres have been considered. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #5: Yes: Dr. Ragni kumari Reviewer #7: Yes: Xuanjie Chen Reviewer #8: Yes: Justice Ofori-Amoah Reviewer #12: Yes: Raul Alberto Cordeiro ********** |
| Formally Accepted |
|
PONE-D-25-04838R2 PLOS ONE Dear Dr. De Silva, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Paolo Landa Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .